A multi-center open-label, phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ICP-192 in patients with advanced solid tumors and FGFR gene alterations

Project: Research

Project Details

AcronymICP-CL-00303
StatusActive
Effective start/end date10/11/2130/11/23